Cite
HARVARD Citation
Kok, P. et al. (2021). Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials. JCO precision oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kok, P. et al. (2021). Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials. JCO precision oncology. p. . [Online].